Alyeska Investment Group
FATE icon

Alyeska Investment Group’s Fate Therapeutics FATE Stock Holding History

Alyeska Investment Group’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-33,285
Closed -$1.14M – 513
2020
Q2 		$1.14M Buy
+33,285
New +$992K 0.02% 398
2018
Q1 		– Sell
-300,000
Closed -$1.83M – 465
2017
Q4 		$1.83M Buy
+300,000
New +$1.34M 0.02% 347
2016
Q1 		– Sell
-168,881
Closed -$569K – 410
2015
Q4 		$569K Sell
168,881
-10,505
-6% -$44.2K 0.01% 353
2015
Q3 		$956K Sell
179,386
-33,781
-16% -$231K 0.01% 392
2015
Q2 		$1.38M Buy
213,167
+130,604
+158% +$781K 0.02% 382
2015
Q1 		$404K Buy
82,563
+6,069
+8% +$30.1K 0.01% 475
2014
Q4 		$385K Buy
76,494
+25,012
+49% +$110K 0.01% 456
2014
Q3 		$263K Buy
51,482
+405
+0.8% +$2.34K 0.01% 366
2014
Q2 		$322K Buy
+51,077
New +$360K 0.01% 384

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return